High Demand for Weight-Loss Drugs Leads to Social Inequities in Access and Affordability in 2024

You can read the full story here: High Demand for Weight-Loss Drugs Leads to Social Inequities in Access and Affordability in 2024 .
Powerful weight-loss drugs like Ozempic, the breakthrough type 2 diabetes treatment, and obesity drug Wegovy, both developed by Danish company Novo Nordisk, came into the public eye last year, offering a new way to tackle record rates of obesity, but the extraordinary demand and high prices will keep them away from the many patients who … Read more